Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Gains from Sales and Divestitures (2019 - 2020)

Historic Gains from Sales and Divestitures for Pliant Therapeutics (PLRX) over the last 2 years, with Q4 2020 value amounting to $163568.0.

  • Pliant Therapeutics' Gains from Sales and Divestitures changed N/A to $163568.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $163568.0, marking a year-over-year change of. This contributed to the annual value of $163568.0 for FY2020, which is N/A changed from last year.
  • Pliant Therapeutics' Gains from Sales and Divestitures amounted to $163568.0 in Q4 2020.
  • Over the past 5 years, Pliant Therapeutics' Gains from Sales and Divestitures peaked at $335610.0 during Q3 2019, and registered a low of $92199.0 during Q2 2020.